Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
593 Eddy St
Providence, RI 02903Phone+1 401-793-9166
Summary
- Clark C. Chen holds the French Lyle Chair in Neurosurgery and serves as the Head of the Neurosurgery program at the University of Minnesota. He specializes in the treatment of brain cancers, with a focus on minimally invasive neuro-oncologic surgeries. Dr. Chen completed his neurosurgery training at the Massachusetts General Hospital, Harvard Medical School in 2008. He pursued an in-folded clinical fellowship in radiosurgery and a second fellowship in stereotactic neurosurgery before joining staff as the Director of Surgical Neuro-Oncology at the Beth Israel Deaconess Medical Center, Harvard Medical School. He was recruited to the University of California San Diego Neurosurgery in 2011, where he rose to the rank of tenured ladder-rank Professor and served as the Vice-Chair of Academic Affairs until his current role. Dr. Chen is an NIH-funded investigator and is active in national and international neurosurgery, including service as an executive committee member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons Tumor Section. He serves as editor and reviewer for over twenty well-regarded journals that span the field of radiosurgery, neurosurgery, clinical medicine, and laboratory research. Dr. Chen is consistently recognized as a “Top Doctor” in Minnesota for his expertise in clinical neurosurgery by the Mpls. St. Paul Magazine as well as Minnesota Monthly.
Education & Training
- Massachusetts General HospitalResidency, Neurological Surgery, 2001 - 2008
- Massachusetts General HospitalInternship, Transitional Year, 2001 - 2002
- Harvard Medical SchoolClass of 2001
Certifications & Licensure
- CA State Medical License 2011 - Present
- RI State Medical License 2023 - 2026
- MN State Medical License 2017 - 2024
- MA State Medical License 2002 - 2011
- American Board of Neurological Surgery Neurological Surgery
Clinical Trials
- Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Roles: Contact
- Spectroscopic Magnetic Resonance Imaging of Glioma Start of enrollment: 2019 Jun 01
Roles: Principal Investigator
- A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma Start of enrollment: 2024 Jun 28
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer ...John Pham, David J Cote, Keiko Kang, Robert G Briggs, David Gomez
Journal of Neuro-Oncology. 2025-02-05 - Vasopressor Use in Acute Spinal Cord Injury: Current Evidence and Clinical Implications.Mazen Taman, Hael Abdulrazeq, Carlin Chuck, Rahul A Sastry, Rohaid Ali
Journal of Clinical Medicine. 2025-01-29 - 1 citationsCell migration simulator-based biomarkers for glioblastoma.Jay Hou, Mariah McMahon, Tyler Jubenville, Jann N Sarkaria, Clark C Chen
Neuro-Oncology Advances. 2024-11-02
Press Mentions
- Rhode Island Hospital First in the State to Offer New Targeted Therapy for Brain TumorsJanuary 24th, 2025
- Brain Cancer Drug Trial Set to Expand Two Years After Saving MN MotherMarch 15th, 2023
- State-of-the-Art Neurosurgery Suite Will Bridge the Gap Between Research and Clinical CareJanuary 3rd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: